Lifeboat Foundation

Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024.

Researchers from the University of Colorado Anschutz Medical Campus have established a new framework for understanding how classic antidepressants work in treating major depressive disorder (MDD), reemphasizing their importance and aiming to reframe clinical conversation around their role in treatment.

Some children with autism experience profound, lifelong difficulties like developmental delay, social struggles and even the inability to speak. Others experience more mild symptoms that improve with time.

In what researchers have called an “unprecedented” response, a new drug that treats locally advanced rectal cancer has shown to have completely eradicated tumors in all 42 patients who took part in the Phase II trial.

The drug, Jemperli (dostarlimab-gxly), had earlier shown great potential for eliminating mismatch repair deficient (dMMR) cancers, which make up 5–10% of colorectal cancers. Following the Phase II trial, the first 24 patients assessed showed a “sustained complete clinical response” – no cancer evident – after an average of 26.3 months.

“These findings demonstrate the potential of dostarlimab-gxly as a novel approach to treating locally advanced dMMR rectal cancer that leads to durable complete tumor regression without the need for life-altering treatment,” said Dr Andrea Cercek, researcher and oncologist at the Memorial Sloan Kettering Cancer Center (MSK). “As a clinician, I’ve seen firsthand the debilitating impact of standard treatment of dMMR rectal cancer and am thrilled about the potential of dostarlimab-gxly in these patients.”

Basically confirmed whats been said here. AI will take over film making by 2029/2030.

Actor and entrepreneur Ashton Kutcher lauded OpenAI’s generative AI video tool Sora at a recent event. “I’ve been playing around with Sora, this latest thing that OpenAI launched that generates video,” Kutcher said. “I have a beta version of it, and it’s pretty amazing. Like, it’s pretty good.”

Continue reading “Actor and investor Ashton Kutcher Lauds OpenAI’s Video Model Sora” »

Prominent investor Ron Baron has come out in support of Tesla CEO Elon Musk’s $56 billion pay package, which is up for a shareholder vote next week, according to an open letter from the Baron Capital founder on Tuesday.

New long-term agreement will help provide responsive access to space for future tech demonstration spacecraft

Cedar Park, Texas, June 5, 2024 – Firefly Aerospace, Inc., an end-to-end space transportation company, today announced it signed a multi-launch agreement with Lockheed Martin for 25 launches on Firefly’s Alpha rocket through 2029. This agreement commits Lockheed Martin to 15 launch reservations and 10 optional launches.

“Firefly is honored to continue this partnership with Lockheed Martin and appreciates their confidence in our rapid launch services to support their critical missions for years to come,” said Bill Weber, CEO of Firefly Aerospace. “The Firefly team has scaled up Alpha production and testing and significantly streamlined our launch operations to fly Alpha more frequently and responsively. This allows us to continue delivering the one metric ton rocket the industry is demanding.”

SpaceX is targeting a launch at 8 a.m. EDT on June 6.

Making Humanity A Multi-Planetary Species — Dr. Eliah Overbey, Ph.D. — Assistant Professor, Bioastronautics, University of Austin; CSO, BioAstra.

Dr. Eliah Overbey, Ph.D. is Assistant Professor of Bioastronautics at The University of Austin (UATX — https://www.uaustin.org/people/eliah–…) where she is involved in pioneering research in the field of astronaut health, specializing in spaceflight-induced genomic changes. Her work focuses on mapping changes in the human body during spaceflight and developing Earth-independent laboratories to make humans a multi-planetary species (https://www.eliahoverbey.com/).

Continue reading “Dr. Eliah Overbey, Ph.D. — Assistant Prof., Bioastronautics, UATX — Making Humanity Multi-Planetary” »